United Natural Foods, Inc. Form 10-Q Summary
Business Context and Reporting Period
UNFI distributes natural, organic, specialty, produce and conventional grocery and non-food products and provides support services to retailers in the United States and Canada. The filing covers the 13-week third quarter and 39-week year-to-date periods ended April 29, 2023, compared with periods ended April 30, 2022. The financial statements are unaudited and prepared under interim U.S. GAAP.
Key Financial Metrics
| Metric | Q3 FY2023 | Q3 FY2022 | FY2023 YTD | FY2022 YTD |
|---|---|---|---|---|
| Net sales | $7,507 million | $7,242 million | $22,855 million | $21,655 million |
| Gross profit | $1,000 million | $1,012 million | $3,165 million | $3,129 million |
| Gross margin | 13.3% | 14.0% | 13.8% | 14.4% |
| Operating income | $33 million | $123 million | $195 million | $355 million |
| Net income attributable to UNFI | $7 million | $67 million | $92 million | $209 million |
| Diluted EPS | $0.12 | $1.10 | $1.51 | $3.44 |
| Adjusted EBITDA | $159 million | $196 million | $547 million | $616 million |
Q3 sales increased 3.7%, while year-to-date sales increased 5.5%, primarily from product-cost inflation and new or expanded business, partly offset by lower units sold. Estimated aggregate product-cost inflation was approximately 8% in Q3.
Q3 operating income margin was approximately 0.4%, compared with 1.7% in the prior-year quarter. The filing does not provide a clearly labeled operating margin for the year-to-date period, but operating income declined materially to $195 million from $355 million.
Net cash provided by operating activities was $402 million year to date, compared with cash used of $31 million in the prior-year period. Capital expenditures were $218 million, compared with $158 million. Cash used in investing activities was $211 million, and cash used in financing activities was $197 million. Cash and cash equivalents ended at $38 million.
Total debt, including the current portion, was $2,032 million at April 29, 2023, down from $2,123 million at July 30, 2022. The company had $1,577 million of unused ABL capacity and total liquidity of $1,615 million, including cash. The $2,600 million ABL facility had $879 million of loans and $144 million of letters of credit outstanding.
Material Changes Versus the Prior Comparable Period
- Sales increased, but gross profit decreased by $12 million in Q3 as lower inflationary benefits and procurement gains, higher shrink and operational-improvement costs pressured margins.
- Q3 Adjusted EBITDA declined $37 million, or approximately 19%, to $159 million. Wholesale Adjusted EBITDA declined 16.4% to $143 million, while Retail Adjusted EBITDA increased 28.6% to $18 million.
- Operating income declined $90 million in Q3 and $160 million year to date. The comparison was adversely affected by the absence of the prior-year $87 million gain from the Riverside, California distribution-center sale-leaseback.
- Q3 operating expenses included an approximately $20 million reversal of previously accrued incentive compensation. Prior-year Q3 operating expenses included approximately $15 million of incentive compensation expense.
- The company monetized certain receivables for initial net proceeds of approximately $253 million. It used proceeds to make a $125 million voluntary term-loan prepayment and reduce ABL borrowings.
- The company repurchased approximately 1.1 million shares for $41 million year to date, with $159 million remaining under the $200 million authorization at April 29, 2023.
Guidance, Outlook, Risks and Unusual Items
- Management expects fiscal 2023 capital expenditures of approximately $350 million, primarily for automation, distribution-network optimization and technology investments.
- Management expects to use internally generated funds and ABL borrowings to fund capital expenditures and debt obligations, while continuing to reduce leverage over the long term. The filing does not provide clear full-year revenue or earnings guidance.
- The transformation program includes network automation and optimization, commercial value creation, digital enhancement and infrastructure modernization. Management expects near-term administrative efficiencies and commercial contract reviews to support profitability.
- Key risks include low and inflation-sensitive margins, customer concentration, lower units sold or consumer spending, supply-chain disruption, labor shortages and union activity, technology implementation, competition, fuel and foreign-exchange volatility, food safety, asset impairments and execution of transformation initiatives.
- The company participates in underfunded multiemployer pension plans. It expects approximately $51 million of fiscal 2023 contributions; a future withdrawal could create material liabilities.
- Non-cancelable future purchase obligations were approximately $524 million, and commitments for signed but not yet commenced leases were $772 million. Guarantees had a maximum undiscounted exposure of $16 million, with an estimated recorded loss of $1 million.
- UNFI remains involved in opioid-related litigation, prescription-pricing claims and a False Claims Act matter. On June 1, 2023, after the quarter end, the U.S. Supreme Court reversed and vacated the lower-court judgment in the FCA case and remanded it for further proceedings. No material legal accrual had been recorded as of April 29, 2023, but management cautions that outcomes could materially affect results.
- Interest-rate exposure is partly hedged through $800 million of floating-rate notional debt under swaps maturing between September 2023 and October 2025. A 100-basis-point change in forward SOFR was estimated to change swap fair value by approximately $10 million.
Most Important Facts to Verify
- Whether gross-margin pressure from reduced inflationary and procurement benefits persists as inflation moderates.
- The sustainability of operating cash flow after the benefit from receivable monetization and the company’s ability to fund approximately $350 million of planned capital expenditures.
- Debt repayment progress, ABL availability, interest-rate exposure and compliance with applicable borrowing-base and covenant requirements.
- Execution, cost and expected returns of the transformation and automation programs, including the Allentown distribution-center ramp-up.
- Potential financial exposure from the remanded False Claims Act litigation, opioid-related matters and multiemployer pension plans.
- The extent to which sales growth reflects inflation rather than unit and volume growth, particularly in Wholesale and Retail.